DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
21 feb 2011 - 08:26
Statutaire naam
DSM B.V.
Titel
DSM Tender Offer for Martek Biosciences Corporation is Successful; DSM Commences Subsequent Offering Period to Allow Additional Tenders
Bericht
Royal DSM N.V. (NYSE Euronext: DSM KON), the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announced today that its tender offer to purchase all of the outstanding shares of common stock of Martek Biosciences Corporation (NASDAQ: MATK), at a price of $31.50 per share, was successful.
Gerelateerde downloads
Datum laatste update: 06 januari 2026